FDA Inspection 1013039 — Zhejiang Haisen Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Haisen Pharmaceutical Co., Ltd. on Apr 21, 2017 in Dongyang. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 21, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Dongyang (China)